Showing results for "Antibodies" in All Categories
-
-
Antibodies
- The X-Files, Book 5
- Written by: Kevin J. Anderson
- Narrated by: Patrick Lawlor
- Length: 7 hrs and 48 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
When a disease-ravaged body is found in the smoldering ruins of the federally funded DyMar genetic research lab, Agents Fox Mulder and Dana Scully fear that a deadly, manmade plague is on the loose. As the FBI agents investigating the X-Files - cases the bureau has deemed unsolvable - Mulder and Scully pursue the truth wherever it leads, even into the labyrinthine corridors of the FBI...and beyond.
-
Antibodies
- The X-Files, Book 5
- Narrated by: Patrick Lawlor
- Series: The X-Files, Book 5
- Length: 7 hrs and 48 mins
- Release Date: 26-05-15
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹468.00 or free with 30-day trial
-
-
-
Antibodies
- Written by: Charles Stross
- Narrated by: Jared Doreck
- Length: 54 mins
- Unabridged
-
Overall0
-
Performance0
-
Story0
Everyone remembers where they were and what they were doing when one of the great and the good is assassinated. You can kill a politician, but their ideas usually live on. They have a life of their own. How much more dangerous, then, the ideas of mathematicians? The announcement of the solution to the traveling salesman problem heralds the imminent destruction of humanity.
-
Antibodies
- Narrated by: Jared Doreck
- Length: 54 mins
- Release Date: 18-09-07
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹258.00 or free with 30-day trial
-
-
-
Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children
- Written by: Annenberg Center for Health Sciences
- Original Recording
-
Overall0
-
Performance0
-
Story0
Respiratory syncytial virus (RSV) is a contagious respiratory infection and a leading cause of illness in children. This activity includes five conversations with experts in nursing, pediatrics, and neonatology. They review RSV basics, current immunoprophylaxis options, and tools to help clinicians prevent RSV in infants and young children, with detailed discussion of RSV antibodies, supporting evidence, and recommendations.
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-
-
Antibody Nation
- Written by: Yannick Franck
- Original Recording
-
Overall0
-
Performance0
-
Story0
Antibody Nation is the official podcast of Antibody label - a platform for uncompromising sound and radical culture.In each episode, we speak with artists who challenge the norm: about their output, their minds, and the worlds they move through.Feel free to support us by buying our releases and merch on antibodylabel.bandcamp.com Hosted on Acast. See acast.com/privacy for more information.
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-
Spotlight on Antibodies
- Written by: Biointron
- Original Recording
-
Overall0
-
Performance0
-
Story0
Spotlight on Antibodies by Biointron is your go-to monthly podcast exploring the latest trends, breakthroughs, and challenges in the antibody industry. From cutting-edge technologies like high-throughput antibody discovery to insights on market shifts and regulatory updates, we bring you expert perspectives and actionable knowledge to stay ahead in this competitive field. Whether you're a biotech professional, researcher, or industry enthusiast, this podcast offers a perfect blend of education and industry updates, helping you stay informed and inspired to innovate.
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-
-
-
A Child Is Still Developing Antibodies to Mountain Dew
- Length: Less than 1 minute
- Release Date: 25-12-16
- Language: English
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
₹48.00 or free with 30-day trial
-
-
-
Podcast on Addressing Key Challenges of Conducting First Monoclonal Antibody (Omalizumab) Study
- Written by: veeda
- Original Recording
-
Overall0
-
Performance0
-
Story0
Welcome to our podcast series, "Unlocking the Mysteries of Monoclonal Antibodies," where we delve deep into the world of cutting-edge medical research. In this episode, we tackle one of the most exciting and challenging topics in the field - conducting the first monoclonal antibody study, specifically focusing on Omalizumab.Monoclonal antibodies have revolutionized modern medicine, offering targeted therapies for a wide range of conditions, from autoimmune diseases to cancer. Omalizumab, in particular, has shown remarkable promise in treating allergic conditions like asthma and chronic ...
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.Add to cart failed.
Please try again laterAdd to wishlist failed.
Please try again laterRemove from wishlist failed.
Please try again laterFollow podcast failed
Unfollow podcast failed
-